Headlines Covid-19 Specialties Trending Feeds Videos

Britain goes it alone over coronavirus. We can only hope the gamble pays off | Devi Sridhar

posted 17 hours

Mashup Score: 525

The Guardian - Ignoring advice and lessons from Europe and Asia on mass testing and isolation, health experts insist that our approach is the...

What a recent Covid-19 flight outbreak tells us about spread on planes

posted 1 day

Mashup Score: 502

Vox - “Is flying safe?” is the wrong...

  • “... flights can be anywhere from safe to unsafe depending on a number of factors. It’s also an example of why viral transmission is not so much a single event, but the result of multiple lapses in safety.” @AbraarKaran https://t.co/m5ZrLzzbZZ

Study: Patients Hospitalized With COVID-19 Have Low Levels of 25-Hydroxyvitamin D

posted 2 days

Mashup Score: 460

Pharmacy Times - One of the more recent potential risk factors of COVID-19 is vitamin D deficiency, which is an important modulator of innate and acquired...

Eli Lilly and Company - The Investor Relations website contains information about Eli Lilly and Company’s business for stockholders, potential investors, and financial...

  • 1st Phase 3 trial results on #SARSCoV2 monoclonal antibody combination with very positive results 1035 patients: 11 (2%) v (7%) for death or hospitalization and 0 vs 10 deaths in high-risk patients, given early https://t.co/BXnwCd64O9 (press release). Coincides w/ EUA criteria. https://t.co/BXnwCd64O9

What happens if the second dose of COVID-19 vaccine is delayed?

posted 1 day

Mashup Score: 321

WPXI - With the uncertainty on the availability of the COVID-19 vaccine, the question of ‘What happens if the second dose is delayed?’ has come...

Sanofi to produce 100 million Pfizer/BioNTech vaccine doses, CEO says

posted 20 hours

Mashup Score: 288

Reuters Health - French pharma giant Sanofi will produce more than 100 million doses of the COVID-19 vaccine developed by its competitors Pfizer and BioNTech by the...

Moderna, Inc. - Out of an abundance of caution, Moderna launches clinical program to boost immunity to emerging variants Manuscript posted to preprint server; company to host...

In a major setback, Merck to stop developing its Covid-19 vaccines – STAT

posted 2 days

Mashup Score: 254

STAT - Merck announced it is stopping development of both of the current formulations of the Covid-19 vaccines the company was working...

  • In a major setback, Merck to stop developing its Covid-19 vaccines - STAT “. . . a reminder that developing new vaccines is difficult, and that the world is lucky that the first two — the Moderna and Pfizer/BioNTech shots — were so effective.” https://t.co/Flyhdm59mf

Overcrowded and overwhelmed: Why Israel’s current COVID-19 wave is the ‘worst yet’

posted 23 hours

Mashup Score: 248

haaretz.com - ...

  • Israel has been lauded for vaccinating over one quarter of its population already. Yet they are seeing the worst wave of COVID-19 yet and can’t figure out why. This should at least raise concerns about the vaccine. https://t.co/THV31WjOta

A year into pandemic, with no cure in sight, ICU doctors take COVID-19 one day at a time

posted 2 days

Mashup Score: 184

MPR News - In a year marked by tragedy and heartbreak, health care providers have been able to study COVID-19 in real time and figure out ways...